Interleukin-13 Promotes Susceptibility to Chlamydial Infection of the Respiratory and Genital Tracts

PLoS Pathogens

Volumn 7, Issue 5, 2011, Pages

  Asquith, Kelly L ^a   Horvat, Jay C ^a   Kaiko, Gerard E ^a   Carey, Alison J ^b   Beagley, Kenneth W ^b   Hansbro, Philip M ^a   Foster, Paul S ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPITHELIUM CELL; GENE EXPRESSION; GENITAL TRACT INFECTION; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MOUSE; NONHUMAN; RESPIRATORY TRACT INFECTION; T CELL DEPLETION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CHLAMYDIA; DISEASE PREDISPOSITION; FEMALE; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; VAGINA DISEASE;

BACTERIA (MICROORGANISMS); CHLAMYDIA MURIDARUM; CHLAMYDIAE; MUS;

ANIMALS; BACTERIAL LOAD; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; FEMALE; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-13; LUNG; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RESPIRATORY TRACT INFECTIONS; VAGINAL DISEASES;

EID: 79958050343     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001339     Document Type: Article

References (63)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT, (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8: 451-461.
2. Blasi F, (2004) Atypical pathogens and respiratory tract infections. Eur Respir J 24: 171-182.
3. World Health Organisation, Department of HIV/AIDS (2001) Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates. Available: http://whqlibdoc.who.int/hq/2001/WHO_HIV_AIDS_2001.02.pdf Accessed 17 March 2011.
4. Jain S, (1999) Perinatally acquired Chlamydia trachomatis associated morbidity in young infants. J Matern Fetal Med 8: 130-133.
5. Rours GI, Hammerschlag MR, Van Doornum GJ, Hop WC, de Groot R, et al. (2009) Chlamydia trachomatis respiratory infection in Dutch infants. Arch Dis Child 94: 705-707.
6. Grayston JT, (1992) Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 15: 757-761.
7. Lyytikainen E, Kaasila M, Koskela P, Lehtinen M, Patama T, et al. (2008) Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect 84: 19-22.
8. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, et al. (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324-331.
9. Hansbro PM, Beagley KW, Horvat JC, Gibson PG, (2004) Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther 101: 193-210.
10. Branden E, Gnarpe J, Hillerdal G, Orre L, Skold CM, et al. (2007) Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema. Int J Chron Obstruct Pulmon Dis 2: 643-650.
11. Branden E, Koyi H, Gnarpe J, Gnarpe H, Tornling G, (2005) Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir Med 99: 20-26.
12. Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, et al. (2009) Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 22: 9-14.
13. Honjo K, van Reekum R, Verhoeff NPLG, (2009) Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 5: 348-360.
14. Wang S, Fan Y, Brunham RC, Yang X, (1999) IFN-γ knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol 29: 3782-3792.
15. Yang X, Gartner J, Zhu L, Wang S, Brunham RC, (1999) IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol 162: 1010-1017.
16. Yang X, HayGlass KT, Brunham RC, (1996) Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 156: 4338-4344.
17. Ito JI, Lyons JM, (1999) Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun 67: 5518-5521.
18. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, et al. (1999) Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 162: 2829-2836.
19. Beatty WL, Byrne GI, Morrison RP, (1993) Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Nat Acad Sci 90: 3998-4002.
20. Zhong GM, de la Maza LM, (1988) Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1. Infect Immun 56: 3322-3325.
21. Chen B, Stout R, Campbell WF, (1996) Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells. FEMS Immunol Med Microbiol 14: 109-120.
22. Hassanain HH, Chon SY, Gupta SL, (1993) Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and-alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor. J Biol Chem 268: 5077-5084.
23. MacMicking J, Xie QW, Nathan C, (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
24. Mehta SJ, Miller RD, Ramirez JA, Summersgill JT, (1998) Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism. J Infect Dis 177: 1326-1331.
25. Igietseme JU, Perry LL, Ananaba GA, Uriri IM, Ojior OO, et al. (1998) Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun 66: 1282-1286.
26. Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, et al. (2008) Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol 180: 2225-2232.
27. Beagley KW, Huston WM, Hansbro PM, Timms P, (2009) Chlamydial infection of immune cells: altered function and implications for disease. Crit Rev Immunol 29: 275-305.
28. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M, (1998) Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 19: 721-727.
29. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC, (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64: 1614-1620.
30. Haranaga S, Yamaguchi H, Ikejima H, Freidman H, Y Y, (2003) Chlamydia pneumoniae infection of alveolar macrophages: A model. J Infect Dis 187: 1107-1115.
31. Debattista J, Timms P, Allan J, Allan J, (2003) Immunopathogenesis of Chlamydia trachomatis infections in women. Fertil Steril 79: 1273-1287.
32. Darville T, Hiltke TJ, (2010) Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 201 (Suppl 2): S114-125.
33. Lee HY, Schripsema JH, Sigar IM, Murray CM, Lacy SR, et al. (2010) A link between neutrophils and chronic disease manifestations of Chlamydia muridarum urogenital infection of mice. FEMS Immunol Med Microbiol 59: 108-116.
34. Hvid M, Baczynska A, Deleuran B, Fedder J, Knudsen HJ, et al. (2007) Interleukin-1 is the initiator of fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol 9: 2795-2803.
35. Skwor TA, Atik B, Kandel RP, Adhikari HK, Sharma B, et al. (2008) Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease. PLoS Negl Trop Dis 2: e264.
36. Wang C, van Ginkel FW, Kim T, Li D, Li Y, et al. (2008) Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice. Infect Immun 76: 4913-4923.
37. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, et al. (2007) Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176: 556-564.
38. Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, et al. (2010) Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 125: 617-625, 625 e611-625 e616.
39. Chen L, Lei L, Chang X, Li Z, Lu C, et al. (2010) Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol 184: 2602-2610.
40. Hansbro PM, Kaiko GE, Foster PS, (2011) Cytokine/anti-cytokine therapy- novel treatments for asthma? Br J Pharmacol In Press.
41. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME, (1998) Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 11: 345-349.
42. Black PN, Scicchitano R, Jenkins CR, Blasi F, Allegra L, et al. (2000) Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 15: 254-259.
43. Wark PAB, Johnston SL, Simpson JL, Hensley MJ, Gibson PG, (2002) Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J 20: 834-840.
44. Webley WC, Tilahun Y, Lay K, Patel K, Stuart ES, et al. (2009) Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections. Eur Respir J 33: 360-367.
45. Matthews DJ, Emson CL, McKenzie GJ, Jolin HE, Blackwell JM, et al. (2000) IL-13 is a susceptibility factor for Leishmania major infection. J Immunol 164: 1458-1462.
46. Muller U, Stenzel W, Kohler G, Werner C, Polte T, et al. (2007) IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 179: 5367-5377.
47. Berry LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, et al. (2004) Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 72: 1019-1028.
48. Yang M, Hogan SP, Henry PJ, Matthaei KI, McKenzie AN, et al. (2001) Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol 25: 522-530.
49. Varin A, Mukhopadhyay S, Herbein G, Gordon S, (2010) Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115: 353-362.
50. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, et al. (2007) T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27: 505-517.
51. Kuo CC, Puolakkainen M, Lin TM, Witte M, Campbell LA, (2002) Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microb Pathog 32: 43-48.
52. Gessner A, Mohrs K, Mohrs M, (2005) Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 174: 1063-1072.
53. Schroeder JT, (2009) Basophils beyond effector cells of allergic inflammation. Adv Immunol 101: 123-161.
54. Kim EY, Battaile JT, Patel AC, You Y, Agapov E, et al. (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 14: 633-640.
55. Kotsimbos TC, Ernst P, Hamid QA, (1996) Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Physicians 108: 368-373.
56. Temann UA, Ray P, Flavell RA, (2002) Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 109: 29-39.
57. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, et al. (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9: 582-588.
58. Metz G, Kraft M, (2010) Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am 30: 575-585, vii-viii.
59. Webley WC, Salva PS, Andrzejewski C, Cirino F, West CA, et al. (2005) The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. Am J Respir Crit Care Med 171: 1083-1088.
60. Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, et al. (2010) Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J Immunol 184: 4159-4169.
61. Beisswenger C, Kandler K, Hess C, Garn H, Felgentreff K, et al. (2006) Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol 177: 1833-1837.
62. Fitzpatrick AM, Holguin F, Teague WG, Brown LA, (2008) Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 121: 1372-1378, 1378 e1371-1373.
63. Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, et al. (2006) Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine 24: 355-366.